Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - Reuter, U; Goadsby, PJ; Lanteri-Minet, M (Lancet, 2018)